A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Initial trials of paclitaxel and doxorubicin in advanced breast cancer yielded high response rates but significant cardiac toxicity was observed. In this phase II trial we investigated the efficacy and safety of paclitaxel combined with epirubicin. Patients with advanced breast cancer, performance s...

Full description

Saved in:
Bibliographic Details
Main Authors: Rischin, D, Smith, J, Millward, M, Lewis, C, Boyer, M, Richardson, G, Toner, G, Gurney, H, McKendrick, J
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2000
Subjects:
Regular Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://ncbi.nlm.nih.gov/pubmed/10945487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1306
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items